A Sun Nuclear-hosted webinar on November 17 will show how Simon unifies QA data and applies statistical process control to identify issues before a tolerance is breached
Mezoo has turned a credit-card-sized chest patch into a monitoring platform used in more than 700 Korean hospitals and clinics.
MIT researchers have shown that they can accurately track muscle movement using tiny magnetic beads implanted in the muscle. These measurements could make it easier for people with certain types of amputations to control their prosthetic limbs.
Senseonics (NYSE: SENS) has launched its first clinical study of a transmitter-free version of its Eversense 365 continuous glucose monitor.
The LoopGo integrates the monitoring unit directly into an adjustable arm cuff, eliminating external tubes and cabling.
SanaHeal has developed a biologically compatible adhesive that sticks to wet tissues to simplify a variety of surgeries.
BURLINGTON, Mass., Oct. 14, 2026 /PRNewswire/ — SQ Innovation today announced that results of the SUBCUT HF II trial of its product Lasix® ONYU have been published in the Journal of the American College of Cardiology (JACC)1, one of the leading peer-reviewed journals in cardiovascular medicine.
BELLEVUE, Wash., Oct. 8, 2026 /PRNewswire/ — Viome PRO, the clinical division of Viome Life Sciences, today launched CancerDetect® Pancreatic, a blood test that looks for pancreatic ductal adenocarcinoma by measuring the enzyme activity associated with the disease. In Viome’s blinded validation, the test detected 86 percent of stage I and II cancers with 90 percent specificity, a performance aimed squarely at the early stages where treatment can still change the outcome. The test is ordered by a physician, drawn as a routine venous sample, and processed in Viome’s CLIA-certified laboratory.
Older people could be monitored safely in their own homes without the need for intrusive cameras or wearable devices thanks to new research by Nottingham Trent University (NTU).
ALTSTÄTTEN, Switzerland and BOSTON, Oct. 6, 2026 /PRNewswire/ — icotec, the global leader in radiolucent implants for spine tumors and other complex spinal surgery patients, today announced that the Centers for Medicare & Medicaid Services (CMS) has approved a New Technology Add-On Payment (NTAP) for icotec’s spine implant system, CMORE® CT, effective October 1, 2026.